Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Exon 20 insertions in NSCLC - ESMO 2020

Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro
Exon 20 insertions in NSCLC - ESMO 2020 ( Dr Alex Spira, Prof Benjamin Besse, Prof Michael Thomas and Dr Antonio Passaro )
25 Sep 2020

ESMO 2020: Lung cancer latest

Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat
ESMO 2020: Lung cancer latest ( Prof Solange Peters, Dr Federico Cappuzzo, Dr Antonio Passaro and Prof Sanjay Popat )
25 Sep 2020

Highlights from ESMO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ESMO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
25 Sep 2020

PARP inhibitors and their evolving role for the treatment of prostate cancer

Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
PARP inhibitors and their evolving role for the treatment of prostate cancer ( Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi )
24 Sep 2020

KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer

Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan
KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer ( Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan )
24 Sep 2020

Disparities in access to oncology clinical trials across Europe

Prof Ana Carneiro - Lund University, Lund, Sweden
Disparities in access to oncology clinical trials across Europe ( Prof Ana Carneiro - Lund University, Lund, Sweden )
24 Sep 2020

ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC

Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC ( Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA )
23 Sep 2020

ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )
23 Sep 2020

Breast cancer roundup from ESMO 2020

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer roundup from ESMO 2020 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
23 Sep 2020

OncoAlert and ecancer weekly roundup for September 14-19, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 14-19, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Sep 2020

IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer

Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer ( Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA )
22 Sep 2020

ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer

Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan
ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer ( Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan )
22 Sep 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation